Welcome to the GIMBE Foundation monitoring page of the COVID-19 epidemic in Italy. GIMBE’s dataroom has been daily powered since February 21th, 2020 with data released by the Civil Protection Department and by the Ministry of Health.
Last updated on 6th August 2020 at 6PM.
Discharged after recovery
Patients isolated at home
Patients hospitalized with symptoms
Patients admitted to the intensive care unit
To be confirmed by National Institute of Health
Prevalence and percentage increase of COVID-19 cases
The graph illustrates how Regions place in relation to the national averages of prevalence and of percentage increase of COVID-19 cases (week 30 July - 6 August).
Covid-19 active cases
The graph illustrates the regional distribution of cases currently positive to Covid-19 (hospitalized patients, patients admitted to the intensive care unit, patients isolated at home).
Absolute change in COVID-19 cases
The graph illustrates the new daily COVID-19 cases in Italy since 3th June 2020.
Percentage increase in COVID-19 cases
The graph illustrates, for each day, the total Italian confirmed cases percentage increase compared to the previous day.
COVID-19 cases: daily trend of diagnostic swabs (cases tested)
The graph illustrates the number of diagnostic swabs and the percentage of positive diagnostic swabs per day.
Geographical distribution of COVID-19 cases
The graph illustrates the geographical distribution of COVID-19 cases in Italy (percentage and absolute value).
Do you want to stay updated on the GIMBE monitoring of the COVID-19 epidemic?
GIMBE data room on COVID-19 pandemic is used for research and dissemination activities.
Wish to help? We will welcome your comments and suggestions on further data processing for public communication.
If you work for an Institution you can ask for specific analyses and forecasting to the GIMBE Foundation.
Contact us: email@example.com
This website has been developed to monitor COVID-19 pandemic.
GIMBE Foundation exclusively answers to requests on processing of official data collected in the data room and will NOT take into consideration questions related to individual behaviours, professional practice, drugs, vaccines and health devices.